# Monro Inc. (MNRO) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Consumer Cyclical / Specialty Retail. Price $11.63, market value $364 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Monro Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.6×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 5.0×**. Enterprise value is 5.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 3.4%** (5-yr avg 13.7%). Free cash flow equals 3.4% of the market value, below its five-year average of 13.7%, so the shares are pricier on cash than usual.

## Profitability
- **Gross margin: 34.8%**. Monro Inc. keeps 34.8% of revenue after the direct cost of what it sells.
- **Operating margin: 1.7%**. 1.7% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 0.2%**. 0.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 0.4%**. 0.4% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 2.4%**. Return on all capital, debt included, is 2.4%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 0.1%**. Each dollar of assets produces 0.1% of profit.

## Growth
- **Revenue growth (1 yr): -3.2%** (3-yr -4.4%/yr, 5-yr 0.6%/yr). Revenue fell 3.2% over the last year, against 0.6% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 113.6%** (3-yr -70.8%/yr, 5-yr -50.5%/yr). Earnings per share rose 113.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -39.6%/yr**. Free cash flow has compounded at -39.6% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.10**. Debt is 0.10 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.6×**. It would take 0.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 0.46** (quick 0.46). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.32**. A Z-score of 1.32 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 9.62%** ($1.12 per share, trailing). Monro Inc. yields 9.62%, high enough to check carefully: yields this high often precede a cut.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 4.9%/yr** (1-yr 0.0%). The dividend has grown 4.9% a year over five years.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Monro Inc.; the consensus is buy, with an average price target of $19.75 (+70% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -13.9%** (YTD -38.0%, 3-mo -5.4%). The shares are down 13.9% over twelve months including dividends.
- **From 52-week high: -51.4%** (5.2% above the low). Trading 51% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): 1.95** (volatility 60%). Beta of 1.95 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MNRO · Page: https://foliofundamentals.com/stocks/mnro

Not investment advice.